Drugs / Hydroxycoloroquine
last change Mar 2021 re-read 2 minutes ago

Hydroxycoloroquine

Developed for
COVID-19

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04853901 Comparator Jul 2020 → Jan 2021 COVID-19 Ain Shams University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hydroxycoloroquine Hydroxycoloroquine 400mg twice on day 1 then 200mg tab twice 2-10 days” NCT04853901